
	Where results make sense

Topic: Amersham plc

Related Topics

Amersham

Elections in Nigeria

Alternative Investment Market

Yacas

Oatley

Abietic acid

Cathar

	Kids.Net.Au - Encyclopedia > Amersham
		Amersham is widely known because of a multinational pharamaceutical company, Amersham plc (now known as Nycomed-Amersham), that took its name from the town.
		Records of Amersham date back to pre-Saxon times, when it was known as Agmodesham, and by the time that the Domesday book was written at around 1086 it became known as Elmodesham.
		Amersham is linked to London by the Metropolitan Line of London Underground, and is now the last station on its branch of this line.
	www.kids.net.au /encyclopedia-wiki/am/Amersham (269 words)

	Amersham - Wikipedia, the free encyclopedia (Site not responding. Last check: 2007-11-03)
		Amersham is widely known because of a multinational pharmaceutical company, Amersham plc (originally known as Amersham International, and acquired in 2004 by the American company General Electric), that took its name from the town.
		Amersham is split into two distinct areas: Amersham on the Hill, which is close to the railway station, and Old Amersham, which contains St. Mary's, a 13th century church, and several old inns.
		Amersham sent two MPs to the unreformed House of Commons, and was considered a rotten borough until the Reform Act 1832 stripped it of its representation.
	en.wikipedia.org /wiki/Amersham (401 words)

	Amersham - Definition, explanation
		Amersham (previously Agmondesham) is a market town 27 miles north west of London, in the Chiltern Hills, England.
		Amersham is widely known because of a multinational pharmaceutical company, Amersham plc (originally known as Amersham International, and acquired in 2004 by the American company General Electric), that took its name from the town.
		Amersham is linked to London by the Metropolitan Line of London Underground and is the last station on its branch of this line.
	www.calsky.com /lexikon/en/txt/a/am/amersham.php (615 words)

	BioCorporate Biotechnology Pharmaceutical and Healthcare Directory
		Amersham plc is a world leader in medical diagnostics and in life sciences, delivering pharmaceutical products for the diagnosis and treatment of disease and technologies for biotechnology research and drug discovery.
		Amersham is about visualising life at all levels within the human body - from the molecules and biochemicals that make our genetic structure, to cells, tissues and organs.
		Amersham Health is dedicated to providing health care professionals with products that expand and improve their diagnostic capabilities and contribute to treatment of disease.
	www.bioportfolio.com /biocorporate/displaysingle.asp?Id=707 (205 words)

	Amersham plc: Company overview
		Amersham shares (AHM) are traded on the London, New York and Oslo stock exchanges and we are part of the FTSE index of Britain's 100 largest public companies.
		Amersham Health provides diagnostic imaging agents which highlight organs, tissues and cells inside the human body, for the early detection, diagnosis and management of disease.
		Amersham has a long-standing commitment to research and development and a strong track record of innovation in both life sciences and medical diagnostics.
	www.amersham.com /about/index.html (528 words)

	BioWorld Today
		LONDON - Amersham plc, the UK's largest life sciences company, agreed to be taken over by General Electric Co. in a £5.7 billion (US$9.5 billion) deal that would create a $13 billion turnover business with a vision to drive the development of personalized medicine.
		Amersham will be combined with GE Medical under a new banner called GE Healthcare Technologies, to be based in the UK.
		Amersham had sales of £1.6 billion in 2002, from two divisions: Amersham Health, which develops and markets imaging agents, and Amersham Biosciences, which develops protein separation equipment and discovery systems.
	www.bioworld.com /servlet/com.accumedia.web.Dispatcher?next=bioWorldHeadlines_article&forceid=31212 (448 words)

	AMERSHAM PLC : Encyclopedia Entry
		Amersham plc was a UK pharmaceutical company, specializing in medical diagnostics and life science products.
		In 2004, Amersham plc was acquired by the American firm General Electric (GE) and incorporated into the GE Healthcare business segment.
		Amersham plc's former business segments have become two business segments of GE Healthcare: GE Healthcare Medical Diagnostics and GE Healthcare Life Sciences, respectively.
	www.bibleocean.com /OmniDefinition/Amersham_plc (123 words)

	Review by HSE's NII of the strategy of Amersham plc for ...
		Amersham plc, formerly Nycomed Amersham plc, is a public company specialising in the development, manufacture and supply of radioisotopes and technology for use in medicine, biotechnology, drug discovery and other applications.
		Amersham has an ongoing programme to decommission these plant areas, some have been completed and a number of others are being worked on.
		Amersham currently expects production on its Grove Centre and Maynard Centre sites to continue for the foreseeable future, but should this not be the case, and earlier closure is necessary, then the strategy is flexible enough to be revised at any time.
	www.hse.gov.uk /nuclear/qqreview/naqqr.htm (1296 words)

	Press Release
		Amersham Health, a business of Amersham plc (www.amersham.com), is the leading global pharmaceutical provider of diagnostic and predictive imaging products and services.
		Amersham Health is dedicated to providing healthcare professionals with products that expand and improve their diagnostic capabilities and contribute to the treatment of disease.
		Amersham Health is committed to finding innovative diagnostic and therapeutic solutions with a focus on cardiology, neurology and cancer.
	www.webmethods.com /News/PressReleases/Details?pressReleaseDetails_param0=2486&hiddenRequest=true (822 words)

	Magnetic Resonance TIP - MRI Database: 'GE Healthcare'
		Amersham Health, was the imaging diagnostics and therapy business of Amersham plc.
		Amersham plc, was a producer of contrast imaging agents used to enhance image quality in X-ray, magnetic resonance imaging, and ultrasound procedures.
		Amersham plc was involved in biotechnology research through its Amersham Biosciences unit, which made scanners, sequencers, microarrays, industrial separations, and other research supplies.
	www.mr-tip.com /serv1.php?type=db1&gid=893 (715 words)

	Imanet: Latest news (Site not responding. Last check: 2007-11-03)
		Amersham Health is dedicated to providing healthcare professionals with products that expand and improve their diagnostic capabilities and contribute to the treatment of disease.
		Amersham Health is committed to finding innovative diagnostic and therapeutic solutions with a focus on cardiology, neurology and cancer.
		Amersham plc is a world leader in medical diagnostics and in life sciences.
	www.imanet.com /news (994 words)

	GE Healthcare - Testimonials - Sir William Castell LVO
		Prior to its acquisition by GE in April 2004, Sir William was Chief Executive of Amersham plc.
		During his tenure with Amersham, he successfully oversaw a major expansion of the business through organic growth and acquisitions, culminating in 1997 with the mergers of Amersham International with Pharmacia Biotech and Nycomed asa.
		The resulting business, Amersham plc, was a world leader in in vivo medical diagnostics and life sciences research technologies.
	www.gehealthcare.com /usen/about/bios/bio_castell.html (347 words)

	Amersham plc Reports First Quarter Sales
		Amersham Health is working with Pfizer to find and develop products that will link early and accurate diagnosis of disease with targeted effective therapy.
		Sir William Castell, Chief Executive, Amersham plc, said, "The first quarter of 2002 has been an important one for the group, with the successful resolution of two critical issues, namely the settlement of the sequencing litigation with Applied Biosystems and the purchase of Pharmacia Corporation's 45 per cent stake in Amersham Biosciences.
		Changes in demand for the products of Amersham plc worldwide or the markets for those products, as well as changes in management's expectation of the development of new markets and the timing of completion of various trials leading to the introduction of new products.
	www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/04-29-2002/0001716074&EDATE= (895 words)

	The Caswell Group UK - Asbestos Case Study: Amersham plc
		Amersham plc is a public company specialising in the development, manufacture and supply of radioisotopes and technology for use in medicine, biotechnology, drug discovery and other applications.
		Amersham has an ongoing programme to decontaminate existing plant for re-use in further production.
		Caswell Environmental Service Ltd has been a term contractor for the Amersham plc for 4 years, undertaking all asbestos abatement and removal works at the Grove Centre.
	www.caswell-asbestos.co.uk /environmental/case_2.htm (187 words)

	The Questor Column
		AMERSHAM International, a company that his given its investors a bouncy ride, delivered some good news ahead of schedule yesterday with the deal to take control of its Japanese diagnostic pharmaceutical associate.
		Amersham gains a Japanese manufacturing base and distribution channel-which is important for any company seeking to penetrate Japan's arcane distribution system and essential if your product is an unstable radio-pharmaceutical.
		Amersham also adds Nihon's annual £14m research and development budget to its own British spending of £8m.
	www.telegraph.co.uk /htmlContent.jhtml?html=/archive/1996/04/25/cxquest.html (907 words)

	Amersham Official Guide
		Situated in the “Gateway to the Chilterns” and with a population of approximately 20,000, Amersham today represents a fascinating blend of the ancient and the modern.
		Within its rural boundaries there are fine examples of some of England’s most appealing architecture dating back to the 15th century and earlier and advanced technology is represented by the Amersham plc engaged on the production of radioactive isotopes for medicine and industry.
		The Amersham - Bensheim Society was founded in 1978 to encourage and develop friendship and understanding between Amersham and its twin town Bensheim in Germany.
	www.localauthoritypublishing.co.uk /councils/amersham/about.html (684 words)

	Amersham plc: Amersham Health
		Amersham Health was formed from the merger between Amersham Healthcare (UK) and Nycomed Imaging (Norway) in October 1997.
		Amersham Health is a market-leading global provider of in vivo medical diagnostic products for the early and accurate detection of disease.
		Amersham Health is the market leader in medical diagnostic imaging, with a 38 per cent global market share.
	www.amersham.com /businesses/Health.html (405 words)

	Amersham plc: Amersham Biosciences
		Amersham Biosciences was formed from the merger between Amersham Life Sciences (UK) and Pharmacia Biotech (Sweden) in 1997.
		Amersham Biosciences provides scientists with the tools to investigate the genetic and molecular basis for human development and disease, and to apply this knowledge to the discovery of new drugs and the manufacture of biologically-based medicines.
		Amersham Biosciences is a leading global provider of products and services used in gene, protein and cell research, drug discovery and development, and biopharmaceutical manufacturing.
	www.amersham.com /businesses/Biosciences.html (428 words)

	The findings of NII's assessment of Amersham plc's ...
		In 1999 Amersham was informed of the requirement to submit a 'site' PSR for its Grove Centre site and it is this review that is the subject of this report.
		Nycomed Amersham plc was formed in the autumn of 1997 by the merging of Amersham International plc (including the subsidiary Amersham Pharmacia Biotech Limited) and Nycomed ASA of Norway.
		The Amersham site is included in the NII's five year rolling programme (Reference 7) to check independently the dose rates, and the associated exposure of members of the public reported by licensees.
	www.hse.gov.uk /nuclear/psrrep5.htm (4945 words)

	Acquisition of Amersham plc -- Satisfaction of Pre-Conditions : ArriveNet Press Releases : Business (Site not responding. Last check: 2007-11-03)
		On 10 October 2003, GE and Amersham announced the pre-conditional recommended Acquisition of Amersham applying a share exchange ratio which, at announcement, valued each Amersham share at 800 pence and the diluted share capital of Amersham at approximately (Pounds)5.7 billion ($9.5 billion).
		It is expected that Amersham's preliminary results for 2003 will be announced and the documentation relating to the Scheme (which will incorporate Amersham's preliminary results) will be despatched to Amersham shareholders in approximately four weeks and it is intended that the Acquisition will complete in early April.
		To the best ofthe knowledge and belief of the directors of Amersham (who have takenall reasonable care to ensure that such is the case) the informationcontained in this announcement is in accordance with the facts anddoes not omit anything likely to affect the import of suchinformation.
	press.arrivenet.com /business/article.php/265110.html (562 words)

	AAAS - AAAS News Release
		These discoveries point to "a way for an organism, down at the cellular level, to respond to changes in its environment in a fairly rapid way, and to maintain its proper activity rhythm," said Rutter, who noted that changes in the circadian cycle in humans have been associated with sleep disorders and depression.
		Amersham Biosciences and Science established the Young Scientists' Prize in 1995 to provide support to molecular biology scientists at an early stage of their careers.
		Amersham Biosciences, the life sciences business of Amersham plc (LSE:NYSE:OSE:AHM) is a world leader in developing and providing integrated systems and solutions for disease research, drug development and manufacture.
	www.aaas.org /news/releases/2002/1120ysp.shtml (1401 words)

	INITION \| News \| Amersham
		Since 1983, with the curtailment of the policy of disposal of radioactive waste in the sea, these concrete and lead-lined drums have been kept in storage.
		Amersham resolved to retrieve the waste, sort and repackage it in a manner suitable for long-term storage.
		Inition's brief was to produce a short and engaging video that would convey to the public the processes Amersham Plc use in order to deal with the waste in a responsible, safe and environmentally acceptable manner.
	www.inition.co.uk /inition/news_2002AmershamSeaDump.htm (330 words)

	BioSpace News for Nycomed Amersham PLC (Site not responding. Last check: 2007-11-03)
		LONDON, Oct. 1 /PRNewswire/ -- Amersham plc (NYSE: NYE) (LSE: NAM; OSE: NYA) today announced the completion of the sale of its remaining stake in Nycomed Pharma to Nordic Capital A/S, the holding company of Nycomed Pharma, for a cash consideration of 123 million pounds sterling.
		Nycomed Amersham, the healthcare group, on Monday said the planned flotation of a 10 per cent stake in Amersham Pharmacia Biotech, a joint venture with Pharmacia of the US, was unlikely to go ahead in current market conditions.
		It was held up until March by a backlog of work at the Securities and Exchange Commission, the US regulator, by which time biotechnology shares had been hit by the downturn in equity markets.
	www.acor.org /drugs/pipeline/companies/news/old/1726.news.orig (692 words)

	Proposed Merger of Amersham Life Science and Pharmacia Biotech
		Based on historic turnover, Amersham Pharmacia Biotech will be the largest research-based biotechnology supplier in the world, with combined annual sales of approximately £430 million ($700 million) and approximately 3,600 employees worldwide, addressing growing market segments in the life science industry.
		Amersham and P&U will use best efforts in the period to January 2000 to prepare the company for partial flotation.
		Amersham is a leading supplier of advanced products and specialized technologies for use in Healthcare and Life Science.
	www.obgyn.net /industry/articles/amersham_pu.htm (833 words)

	Pharmaceutical Technology - Shanghai Nycomed Pharmaceutical Manufacturing Plant - China
		The new facility cost a total of $34m to build and was in operation by mid-2001 and producing in excess of five million units of contrast agent per year.
		Nycomed Amersham was a well known producer of radiotherapy and medical diagnostic products and the SNPC plant supplied the Chinese market with Nycomed Amersham's non-ionic X-ray contrast agents as well as other contrast media products.
		Nycomed Amersham, as the senior partner in the enterprise, was expected to provide most of the technology as well as most of the initial capital.
	www.pharmaceutical-technology.com /projects/shanghai2 (984 words)

	Amersham plc stock - The gift of a single share.
		Amersham plc stock - The gift of a single share.
		Amersham plc is engaged in medical diagnostics and in life sciences, delivering pharmaceutical products for the diagnosis and treatment of disease and technologies for biotechnology research and drug discovery.
		Amersham has research, development and manufacturing facilities in Europe, North America, Japan and China.
	www.singleshare.com /stocks/ahm.shtml (82 words)

	Nycomed Amersham Imaging launches Website
		Nycomed Amersham Imaging's ONCOSEED brand of I-125 seeds is a tiny radioactive seed implanted into the prostate where they irradiate the tumor (typically around 100 seeds are implanted).
		Nycomed Amersham Imaging is a research-based pharmaceutical company dedicated to providing health care professionals with products that expand and improve their diagnostic capabilities and contribute to treatment of disease.
		Nycomed Amersham plc is a world leader in in-vivo diagnostic imaging and in life sciences.
	www.psa-rising.com /wiredbird/nycomedamersham110299.htm (603 words)

Try your search on: Qwika (all wikis)